Penilaian MPV dan Agregasi Trombosit pada Penderita Diabetes Mellitus Tipe 2

  Kuenzi JA. Diabetes mellitus and the metabolic syndrome. In: Porth C (ed.).

  rd Essentials of Pathophysiology: Concepts of Altered Health States, 3 edition .

  China: Lippincott Williams & Wilkins. 2011. p: 805-808.

  2. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2010;33(Suppl 1), S62-S69.

  3. American Diabetes Association. Standards of Medical Care in Diabetes- 2010. Diabetes Care. 2010;33(Suppl 1), S11-S61.

  4. Harrison LC, Wentworth JM, Elkassaby S, Fourlanos S, Greenbaum CJ.

  Reappraising the stereotypes of diabetes. In: Greenbaum CJ, Harrison LC (ed.). Diabetes: Translating Research into Practice. New York: Informa Healthcare. 2008. p: 1-15.

  5. Powers AC. Diabetes mellitus. In: Fauci AS, Braunwald E, Hauser SL, et.al.

  th

  (ed.). Harrison’s Principles of Internal Medicine, 17 edition . San Francisco: McGraw-Hill Companies. 2008. p: 2275-302.

  6. Buse MG. Hexosamine, insulin resistance, and the complication of diabetes: current status. Am J Physiol Endocrinol Metab. 2006:290:E1-E8.

  7. Shaw JE, Sicree RA, Zimmet PZ. Global Estimates of the Prevalence of Diabetes for 2010 and 2030. Diabetes Research and Clinical Practice.

  2010;87, 4-14.

  8. Ministry of Health, Republic of Indonesia. Centre of Data and Information

  Indonesia Health Profile 2008 . Jakarta; Ministry of Health Republic of Indonesia 2010.

  9. Grant PJ. Diabetes Mellitus as A Prothrombotic Condition. Journal of Internal Medicine . 2007;262(2):157-72.

  10. Ferreiro JL, Gomez-Hospital JA, Angiolillo DJ. Platelet Abnormalities in Diabetes Mellitus. Diabetes and Vascular Disease Research. 2010;7(4):251- 259.

  11. Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL. Platelet Dysfunction in Type 2 Diabetes. Diabetes Care. 2001;24(8):1476-85.

  12. Ostermann H, van de Loo J. Factors of the Hemostatic System in Diabetic Patients: A Survey of Controlled Studies. Haemostasis. 1986;16:386-416.

  13. Stratmann B, Menart B, Tschoepe D. Diabetes mellitus. In: Michelson AD (ed.). Platelets, 2

  nd edition . New York: Elsevier Inc. 2007. p:697-711.

  14. Harrison P, Keeling D. Clinicat test of platelet function. In: Michelson AD (ed.). Platelets, 2

  nd edition . New York: Elsevier Inc. 2007. p:445-74.

  15. Zhou L, Schmaier AH. Platelet Aggregation Testing in Platelet-Rich Plasma: Description of Procedure with the Aim to Develop Standards in the Field. Am J Clin Pathol . 2005;123:172-183.

  16. Kueh YK, Lim BC, Chan L. Increased Platelet Aggregation in Diabetes Mellitus. Singapore Medical Journal. 1982;23:3.

  17. Gϋven F, Yilmaz A, Aydin H, et.all. Platelet Aggregation Responses in Type 2 Diabetic Patients. HEALTH. 2010;2:708-712.

  18. Miller CH. Platelet Aggregation Studies. In: Hillyer CD, Shaz BH, Zimring JC, Abshire TC (ed.). Transfusion Medicine and Hemostasis: Clinical and

  Laboratory Aspect . China: Elsevier Inc. 2009. p: 19.

  George JN. Platelets. Lancet. 2000;355:1531-1539.

  20. Bath PM, Buttherworth RJ. Platelet Size: Measurement, Physiology and Vascular Disease. Blood Coagulation & Fibrinolysis. 1996;7(2):157-61.

  21. Bancroft AJ, Abel EW, Mclaren M, Belch JJ. Mean Platelet Volume is A Useful Parameter: A Reproducible Routine Method Using A Modified Coulter Thrombocytometer. Platelets. 2000;11(7):379-87.

  22. Zuberi BF, Akhtar N, Afsar S. Comparison of Mean Platelet Volume in Patients with Diabetes Mellitus, Impaired Fasting Glucose and Non-diabetic Subjects. Singapore Medical Journal. 2008;49(2):114.

  23. Papanas N, Symeonidis G, Maltezos E, et.all. Mean Platelet Volume in Patients with Type 2 Diabetes Mellitus. Platelets. 2004;15(8):475-8.

  24. Hekimsoy Z, Payzin B, Ornek T, Kandoğan G. Mean Platelet Volume in Type 2 Diabetic Patients. Jounal of Diabetes and its Complication.

  2004;18(3):173-6.

  25. Stettler C, Allemann S, Jϋni P, et.all. Glycemic Control and Macrovascular Disease in Types 1 and 2 Diabetes Mellitus: Meta-analysis of Randomized Trials. American Heart Journal. 2006;152(1):27-38.

  26. Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T. The Relationship Between Glycemic Control and Platelet Activity in Type 2 Diabetes Mellitus. Journal of Diabetes and its Complications. 2009;23(2):89- 94.

  27. Silbernagl S, Lang F. Color Atlas of Pathophysiology. Jakarta: EGC. 2006. p:286-291.

  28. Italiano JE. The Structure and Production of Blood Platelets. In: Gresele P, Fuster V, Page JA, et al. (ed.). Platelets in Hematologic and Cardiovascular Disorders . UK: Cambridge University Press. 2008. p: 1-15.

  29. Kaushansky K, Roth GJ. Megakaryocytes and Platelets. In : Greer JP,

  th

  Foerster J, Lukens JN, et al. (ed.). Wintrobe`s Clinical Hematology, 11 edition . USA: Lippincott Williams and Wilkins. 2004. p: 619-634.

  30. Miller JL, Rao K. Blood Platelets and von Willebrand Disease. In: McPherson RA, Pincus MR. Henry`s Clinical Diagnosis and Management by

  st

Laboratory Methods, 21 edition . USA: Elsevier. 2007. p: 747-754; 764-765

31.

  Ikeda Y, Matsubara Y, Kamata T. Platelet Immunology: Structure, Functions and Polymorphisms of Membrane Glycoproteins. In: Gresele P, Fuster V, Page JA, et al. (ed.). Platelets in Hematologic and Cardiovascular Disorders. UK: Cambridge University Press. 2008. p: 21-30 32. Jurk K, Kehrel BE. Platelets:Physiology and Biochemistry. Seminars in Thrombosis and Hemostasis . 2005;31(4): 381-390.

  33. Calverley DC, Maness LJ. Platelet Function in Hemostasis and Thrombosis.

  In: Greer JP, Foerster J, Lukens JN, et al. (ed.). Wintrobe`s Clinical

  th Hematology, 11 edition . USA: Lippincott Williams and Wilkins. 2004. p: 651-669.

  34. Brass LF, Stalker TJ. Mechanism of Platelet Activation. In: Gresele P, Fuster V, Page JA. et al.(ed.). Platelets in Hematologic and Cardiovascular . UK: Cambridge University Press. 2008. p: 37-48.

  Disorders 35.

  Suharti C. Dasar-Dasar Hemostasis. Dalam: Sudoyo AW, Setiyohadi B, Alwi I, dkk. (ed.). Buku Ajar Ilmu Penyakit Dalam. Edisi 4. Jakarta: Pusat Penerbitan Ilmu Penyakit Dalam FK UI. 2006. p: 749-754.

  36. Tambunan KL. Patogenesis Trombosis. Dalam: Sudoyo AW, Setiyohadi B, Alwi I, dkk. (ed.). Buku Ajar Ilmu Penyakit Dalam. Edisi 4. Jakarta: Pusat Penerbitan Ilmu Penyakit Dalam FK UI. 2006. p: 755-758.

  37. Ofosu FA. Review The Blood Platelet as a Model for Regulating Blood Coagulation on Cell Surfaces and Its Consequences. Biochemistry (Moscow).

  2002;67(1):47-55.

  38. Setiabudy RD. Pemantauan Obat Anti Trombosit. Dalam: Pendidikan Berkesinambungan Patologi Klinik. Jakarta: Bagian Patologi Klinik FK UI.

  2004. p: 121-133.

  39. Cox D. Platelet Function Studies. In: Quinn M, Fitzgerald D (ed.). Platelet

  Function: Assessment, Diagnosis and Treatment . New Jersey: Humana Press Inc. 2005.

  40. Watson SP, Harrison P. The Vascular Function of Platelets. In: Hoffbrand

  th AV, Catovsky D, Tuddenham EG. Postgraduate Haematology, 5 edition.

  USA: Blackwell Publishing. 2005. p: 808-24.

  41. Michelson AD, Furman MI. Markers of Platelet Activation and Granule Secretion. In: Quinn M, Fitzgerald D, eds. Platelet Function; Assessment, Diagnosis and Treatment . New Jersey: Humana Press. 2005. p: 307.

  42. Ferroni P, Basili S, Falco A, Davi G. Platelet Activation in Type 2 Diabetes Mellitus. Journal of Thrombosis and Haemostasis. 2004;2:1282-1291.

  43. Stratmann B, Menart B, Tschoepe D. Diabetes Mellitus. In: Michelson AD

  nd (ed.). Platelets, 2 edition . New York: Elsevier Inc. 2007. p: 697-704.

  44. Yngen M. Platelet Hyperactivity in Diabetes Mellitus. Business Briefing:

  European Cardiology . 2005

  45. Duke WW. The Relation of Blood Platelets to Hemorrhagic Disease.

  Description of A Method for Determining the Bleeding Time and the Coagulation Time and Report of Three Cases of Hemorrhagic Disease Relieved by Blood Transfusion. JAMA. 1910;55:1185-1192.

  46. The British Society for Haematology (BCSH) Haemostasis and Thrombosis Task Force. Guidelines on Platelet Function Testing. J Clin Pathol.

  1988;41:1322-1330.

  47. Brecher G, Schneiderman M, Cronkite EP. The Reproducibility and Constancy of the Platelet Count. Am J Clin Pathol. 1953;23:15-26.

  48. Nilsson IM, Maggnusson S, Borchgrevink C. The Duke and Ivy Methods for Determination of the Bleeding Time. Thromb Diath Haemorrh. 1963;10:223- 234.

  49. Rodgers RP, Levin J. A Critical Reappraisal of the Bleeding Time. Semin Thromb Hemost . 1990;16:1-20.

  50. Peterson P, Hayes TE, Arkin CF, et al. The Preoperative Bleeding Time Test Lacks Clinical Benefit: College of American Pathologists’ and American Society of Clinical Pathologists’ Position Article. Arch Surg. 1998;133:134- 139.

  51. Born GV. Aggregation of Blood Platelets by Adenosine Diphosphate and Its Reversal. Nature. 1962;194:927-929.

  52. O’Brien JM. Platelet Aggregation. II. Some Results from a New Method of Study. J Clin Pathol. 1962;15:452-481.

  53. Jennings LK, White MM. Platelet Aggregation. In: Michelson AD (ed.).

  nd Platelets , 2 edition. New York. Elsevier Inc. 2007.

  54. White MM, Jennings LK. Platelet Protocol: Research and Clinical Laboratory Procedures . San Diego. Academic Press. 1999.

  55. Castellone D. Overview of Hemostasis and Platelet Physiology. In: Ciesla B (ed.). Hematology in Practice. Philadelphia. FA Davis Company. 2007.

  56. Perry D, Todd T. Practical-Haemostasis. A Practical Guide to Laboratory Haemostasis. Platelet Function Testing: Light Transmission Aggregometry (LTA) . 2011.

  57. Hubbard JD. Hemostasis and Coagulation. In: Hubbard JD (ed.). A Concise

  nd Review of Clinical Laboratory Science, 2 edition . Philadelphia. Lippincott Williams & Wilkins. 2010.

  58. O’Malley T, Langhorne P, Elton RA, Stewart C. Platelet Size in Stroke Patients. American Heart Association. 1995;26:995-999.

  59. Bambang M, Moeslichan S, Sastroasmoro S, Budiman I, Purwanto S.

  Perkiraan besar sampel. In: Sastroasmoro S, Ismael S (ed.). Dasar-dasar Metodologi Penelitian . Jakarta: Sagung Seto, 2008. p: 302-39.

  60. Wahyuni A. Statistika Kedokteran. Medan: Bamboedoea Communication, 2011. p: 120.

  61. Shaw J, Zimmet P. Early detection and prediction of type 2 diabetes. In: Greenbaum CJ, Harrison LC (ed.). Diabetes: Translating Research into . New York: Informa Healthcare. 2008. p: 41-55.

  Practice 62.

  Hubbard J. Routine hematology. In: Hubbard J (ed.). A Concise Review of

  nd Clinical Laboratory Science, 2 edition . Philadelphia: Lippincott Williams & Wilkins. 2010. p: 85-116.

  63. van Leeuwen A, Poelhuis-Leth D. Davis’s Comprehensive Handbook of

  rd Laboratory and Diagnostic Tests with Nursing Implications, 3 edition .

  Philadelphia: FA Davis Company. 2009. p: 378-9.

  64. Pound N, Sturrock NDC, Jeffcoate WJ. Age Related Changes In Glycated Haemoglobin In Patients With Insulin-Dependent Diabetes Mellitus. Diabetic Medicine . 1996;13(6):510-13.

  65. Siddiqui MA, Khan MF, Carline TE. Gender Difference in Living with Diabetes Mellitus. Mater Sociomed. 2013;25(2):140-142.

  66. Ford ES, Cowie CC, Li C, Handelsman Y, Bloomgarden ZT. Iron-deficiency Anemia, Non-iron-deficiency Anemia and HbA1c Among Adults in the US.

  J Diabetes . 2011;3(1):67-73.

  67. Sterner G, Carlson J, Ekberg G. Raised Platelet Levels in Diabetes Mellitus Complicated with Nephropathy. Journal of Internal Medicine. 1998;244:437- 441.

  68. Sharpe PC, Trinick T. Mean Platelet Volume in Diabetes Mellitus. QJM.

  1993;86(11):739-742.

  69. Kodiatte TA et. al. Mean Platelet Volume in Type 2 Diabetes Mellitus. J Lab Physicians . 2012;4(1):5-9.

  70. Űnűbol M, Ayhan M, Gűney E. The Relationship Between Mean Platelet Volume With Microalbuminuria and Glycemic Control in Patients With Type II Diabetes Mellitus. Platelets. 2012;23(6):475-80.

  71. Khan SR, Ayub N, Nawab S, Shamsi TS. Triglyceride Profile in Dyslipidaemia of Type 2 Diabetes Mellitus. Journal of the College of Physicians and Surgeons Pakistan . 2008;18(5):270-273.

  72. Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. Platelet Size as A Determinant of Platelet Function. J Lab Clin Med.

  1983;101(2):205-13.

  73. Vivas D et. al. Influence of HbA1c Levels on Platelet Function Profiles Associated with Tight Glycemic Control in Patients Presenting with Hyperglycemia and An Acute Coronary Syndrome. A Subanalysis of the CHIPS study. J Thromb Thrombolysis. 2013;35(2):165-74.